BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18083562)

  • 1. Prodrug thiamine analogs as inhibitors of the enzyme transketolase.
    Le Huerou Y; Gunawardana I; Thomas AA; Boyd SA; de Meese J; Dewolf W; Gonzales SS; Han M; Hayter L; Kaplan T; Lemieux C; Lee P; Pheneger J; Poch G; Romoff TT; Sullivan F; Weiler S; Wright SK; Lin J
    Bioorg Med Chem Lett; 2008 Jan; 18(2):505-8. PubMed ID: 18083562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, in vitro and in vivo activity of thiamine antagonist transketolase inhibitors.
    Thomas AA; Le Huerou Y; De Meese J; Gunawardana I; Kaplan T; Romoff TT; Gonzales SS; Condroski K; Boyd SA; Ballard J; Bernat B; DeWolf W; Han M; Lee P; Lemieux C; Pedersen R; Pheneger J; Poch G; Smith D; Sullivan F; Weiler S; Wright SK; Lin J; Brandhuber B; Vigers G
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2206-10. PubMed ID: 18267359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-charged thiamine analogs as inhibitors of enzyme transketolase.
    Thomas AA; De Meese J; Le Huerou Y; Boyd SA; Romoff TT; Gonzales SS; Gunawardana I; Kaplan T; Sullivan F; Condroski K; Lyssikatos JP; Aicher TD; Ballard J; Bernat B; DeWolf W; Han M; Lemieux C; Smith D; Weiler S; Wright SK; Vigers G; Brandhuber B
    Bioorg Med Chem Lett; 2008 Jan; 18(2):509-12. PubMed ID: 18182286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and in vitro/in vivo evaluation of orally bioavailable prodrugs of a catechol-O-methyltransferase inhibitor.
    Rautio J; Leppänen J; Lehtonen M; Laine K; Koskinen M; Pystynen J; Savolainen J; Sairanen M
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2614-6. PubMed ID: 20231095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell permeation of a Trypanosoma brucei aldolase inhibitor: evaluation of different enzyme-labile phosphate protecting groups.
    Azéma L; Lherbet C; Baudoin C; Blonski C
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3440-3. PubMed ID: 16632348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semicarbazone-based inhibitors of cathepsin K, are they prodrugs for aldehyde inhibitors?
    Adkison KK; Barrett DG; Deaton DN; Gampe RT; Hassell AM; Long ST; McFadyen RB; Miller AB; Miller LR; Payne JA; Shewchuk LM; Wells-Knecht KJ; Willard DH; Wright LL
    Bioorg Med Chem Lett; 2006 Feb; 16(4):978-83. PubMed ID: 16290936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Features of thiamine diphosphate-dependent enzyme inhibition by oxodihydrothiochrome and its phosphorylated derivatives].
    Zimatkina TI; Chernikevich IP; Zabrodskaia SV; Kuznetsova AS; Oparin DA; Stepuro II; Ostrovskiĭ IuM
    Ukr Biokhim Zh (1978); 1991; 63(2):59-65. PubMed ID: 1882465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diphenyl urea derivatives as inhibitors of transketolase: a structure-based virtual screening.
    Obiol-Pardo C; Alcarraz-Vizán G; Cascante M; Rubio-Martinez J
    PLoS One; 2012; 7(3):e32276. PubMed ID: 22403640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanical insights of oxythiamine compound as potent inhibitor for human transketolase-like protein 1 (TKTL1 protein).
    Mariadasse R; Biswal J; Jayaprakash P; Rao GR; Choubey SK; Rajendran S; Jeyakanthan J
    J Recept Signal Transduct Res; 2016; 36(3):233-42. PubMed ID: 26481897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 5-(4-carboxymethylphenyl)-1-(4-methanesulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its aminosulfonyl analog: Synthesis, biological evaluation and nitric oxide release studies.
    Abdellatif KR; Chowdhury MA; Dong Y; Das D; Yu G; Velázquez C; Suresh MR; Knaus EE
    Bioorg Med Chem; 2009 Jul; 17(14):5182-8. PubMed ID: 19500994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of prodrug 4-chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl benzoate (TG100801): a topically administered therapeutic candidate in clinical trials for the treatment of age-related macular degeneration.
    Palanki MS; Akiyama H; Campochiaro P; Cao J; Chow CP; Dellamary L; Doukas J; Fine R; Gritzen C; Hood JD; Hu S; Kachi S; Kang X; Klebansky B; Kousba A; Lohse D; Mak CC; Martin M; McPherson A; Pathak VP; Renick J; Soll R; Umeda N; Yee S; Yokoi K; Zeng B; Zhu H; Noronha G
    J Med Chem; 2008 Mar; 51(6):1546-59. PubMed ID: 18311895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel small-molecule inhibitors for human transketolase by high-throughput screening with fluorescent intensity (FLINT) assay.
    Du MX; Sim J; Fang L; Yin Z; Koh S; Stratton J; Pons J; Wang JJ; Carte B
    J Biomol Screen; 2004 Aug; 9(5):427-33. PubMed ID: 15296642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning and characterization of Plasmodium falciparum transketolase.
    Joshi S; Singh AR; Kumar A; Misra PC; Siddiqi MI; Saxena JK
    Mol Biochem Parasitol; 2008 Jul; 160(1):32-41. PubMed ID: 18456347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homology modeling of human transketolase: description of critical sites useful for drug design and study of the cofactor binding mode.
    Obiol-Pardo C; Rubio-Martinez J
    J Mol Graph Model; 2009 Feb; 27(6):723-34. PubMed ID: 19111488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transketolase inhibitors].
    Kochetov GA; Izotova AE
    Biokhimiia; 1973; 38(5):954-7. PubMed ID: 4592477
    [No Abstract]   [Full Text] [Related]  

  • 16. Analogues of key precursors of aspartyl protease inhibitors: synthesis of trifluoromethyl amino epoxides.
    Tam NT; Magueur G; Ourévitch M; Crousse B; Bégué JP; Bonnet-Delpon D
    J Org Chem; 2005 Jan; 70(2):699-702. PubMed ID: 15651823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiamine supplementation to cancer patients: a double edged sword.
    Boros LG; Brandes JL; Lee WN; Cascante M; Puigjaner J; Revesz E; Bray TM; Schirmer WJ; Melvin WS
    Anticancer Res; 1998; 18(1B):595-602. PubMed ID: 9568183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metabolic effects related to transketolase inhibition].
    Gorbach ZV; Ostrovskiĭ IuM; Maglysh SS; Borodinskiĭ AN
    Vopr Med Khim; 1980; 26(5):608-12. PubMed ID: 7423874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-Based Discovery and Synthesis of Potential Transketolase Inhibitors.
    Huo J; Zhao B; Zhang Z; Xing J; Zhang J; Dong J; Fan Z
    Molecules; 2018 Aug; 23(9):. PubMed ID: 30142874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for antibiotic action of the B
    Rabe von Pappenheim F; Aldeghi M; Shome B; Begley T; de Groot BL; Tittmann K
    Nat Chem Biol; 2020 Nov; 16(11):1237-1245. PubMed ID: 32839604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.